1. Home
  2. CIX vs CRDF Comparison

CIX vs CRDF Comparison

Compare CIX & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CompX International Inc.

CIX

CompX International Inc.

N/A

Current Price

$24.00

Market Cap

296.5M

ML Signal

N/A

Logo Cardiff Oncology Inc.

CRDF

Cardiff Oncology Inc.

HOLD

Current Price

$2.51

Market Cap

142.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CIX
CRDF
Founded
1993
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
296.5M
142.1M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
CIX
CRDF
Price
$24.00
$2.51
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$10.63
AVG Volume (30 Days)
13.3K
917.3K
Earning Date
11-05-2025
11-06-2025
Dividend Yield
8.96%
N/A
EPS Growth
2.86
N/A
EPS
1.57
N/A
Revenue
$159,004,000.00
$501,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.52
N/A
Revenue Growth
5.52
N/A
52 Week Low
$17.89
$1.90
52 Week High
$32.30
$5.64

Technical Indicators

Market Signals
Indicator
CIX
CRDF
Relative Strength Index (RSI) 61.74 64.20
Support Level $20.29 $2.32
Resistance Level $24.62 $2.59
Average True Range (ATR) 0.76 0.14
MACD 0.34 0.03
Stochastic Oscillator 87.41 87.61

Price Performance

Historical Comparison
CIX
CRDF

About CIX CompX International Inc.

Compx International Inc is a manufacturer of security products. Its security products are used in recreational transportation, postal, office & institutional furniture, cabinetry, tool storage, healthcare, and a variety of other industries. Also, it is engaged in the manufacturing of stainless steel exhaust systems, gauges, throttle controls, and trim tabs for the recreational marine industry. The company's operating segment includes Security Products and Marine Components. The company generates maximum revenue from the Security Products segment, which manufactures mechanical and electrical cabinet locks and other locking mechanisms. Its geographical segments are the United States, Canada, Mexico, and others, of which the United States accounts for the vast majority of revenue.

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.

Share on Social Networks: